Development of Cryptomonadales technology The research and development of Cryptomonadales: 1992 A new elliptic unicellular plant was found (International Cryptomonadales Biotechnology Co., Ltd- President Wang, Shun-Te) (Institute of botany, Academia Sinica- Huang, Tan-Chi) 1997 30 people tested voluntarily(60 tablets/per day for one month) Summing-up about the efficacy and side-effect of Cryptomonadales (National Cheng Kung University Medical College- Professor Su, Ih-Jen) 2002 Apply for registration of health food(lower cholesterol, The Institute Biochemical Engineering Research Laboratories- Executive: Pan, Yi Hong) Cryptomonadales contains high density of α-Linolenic, C18 and C20 unsaturated fatty acid, etc. 2004 Cryptomonadales contains high density of PPARs active agent (Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes- Dr. Chao, Yu-Sheng) Clinical Trials of Psoriatic arthritis (dermatology department of National Cheng Kung University Hospital- Julia Yu-Yun Lee) 2005 The registration of health food approved (lower triglyceride and low density ~July lipoprotein-cholesterol) (Health Food Certificate A00066, Department of Health, executive Yuan,) 2006 Cooperation on Cryptomonadales cosmetics(anti-ageing) and biomedical technology (regulate ~July blood sugar) (The Institute Biochemical Engineering Research Laboratories- Lee, Lain-Tze, Pan, Yi Hong) 2006 Clinical trials on toxicology of Cryptomonadales PPARs active agent (Development Center for ~July Biotechnology, DCB- toxicology center)